Novel treatments in bleeding disorders: The European Haemophilia Consortium Review

David Page | 22/06/2021

• KEYWORDS

  ADVOCACY ageing A GLOBAL PERSPECTIVE AIDS CARRIERS CHS chapters Community COMPENSATION COVID-19 EMICIZUMAB GENE THERAPY HALF-LIFE FACTOR CONCENTRATES HEMLIBRA HEMOPHILIA A AND B HEPATITIS C HIV ICHIP INHIBITORS MYCBDR NURSING PHYSIOTHERAPY Platelet function disorders PROBE PROPHYLAXIS RARE BLEEDING DISORDERS RESEARCH SOCIAL WORK Tainted blood tragedy THE BLOOD FACTOR THE FEMALE FACTOR THERAPIES THE SAGE PAGE TWINNING VON WILLEBRAND DISEASE